Jeonjinbio Co. Ltd (110020) - Total Liabilities

Latest as of September 2025: ₩1.27 Billion KRW ≈ $862.54K USD

Based on the latest financial reports, Jeonjinbio Co. Ltd (110020) has total liabilities worth ₩1.27 Billion KRW (≈ $862.54K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 110020 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Jeonjinbio Co. Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how Jeonjinbio Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Jeonjinbio Co. Ltd total assets.

Jeonjinbio Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Jeonjinbio Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
ShreeOswal Seeds And Chemicals Limited NSE:OSWALSEEDS	India	Rs895.11 Million
See Hup Consolidated Bhd KLSE:7053	Malaysia	RM50.61 Million
OPG POWER VENTURES (OPB.SG) STU:OPB	Germany	€64.61 Million
Surana Solar Limited NSE:SURANASOL	India	Rs98.95 Million
Malpac Holdings Bhd KLSE:4936	Malaysia	RM8.95 Million
Clean & Science co. Ltd KQ:045520	Korea	₩54.59 Billion
Samyoung S&C Co. Ltd. KQ:361670	Korea	₩2.85 Billion
Equus Total Return Closed Fund NYSE:EQS	USA	$5.74 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Jeonjinbio Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Jeonjinbio Co. Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jeonjinbio Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jeonjinbio Co. Ltd (2015–2024)

The table below shows the annual total liabilities of Jeonjinbio Co. Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩1.19 Billion ≈ $807.71K	-89.62%
2023-12-31	₩11.48 Billion ≈ $7.78 Million	+37.39%
2022-12-31	₩8.36 Billion ≈ $5.66 Million	-40.38%
2021-12-31	₩14.02 Billion ≈ $9.50 Million	+89.15%
2020-12-31	₩7.41 Billion ≈ $5.02 Million	+111.04%
2019-12-31	₩3.51 Billion ≈ $2.38 Million	+9.45%
2018-12-31	₩3.21 Billion ≈ $2.17 Million	-16.15%
2017-12-31	₩3.83 Billion ≈ $2.59 Million	+7.86%
2016-12-31	₩3.55 Billion ≈ $2.40 Million	-55.35%
2015-12-31	₩7.95 Billion ≈ $5.39 Million	--

About Jeonjinbio Co. Ltd

KQ:110020 Korea Specialty Chemicals

Market Cap

$13.57 Million

₩20.02 Billion KRW

Market Cap Rank

#26374 Global

#1989 in Korea

Share Price

₩2210.00

Change (1 day)

+3.03%

52-Week Range

₩1641.00 - ₩3025.00

All Time High

₩16700.00